214 related articles for article (PubMed ID: 32848272)
1. Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19).
Krvavac A; Patel TP; Karle EM; Epstein NB; Reznikov EA; Gates LG; Holliday ZM
Mo Med; 2020; 117(4):346-354. PubMed ID: 32848272
[TBL] [Abstract][Full Text] [Related]
2. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
[TBL] [Abstract][Full Text] [Related]
3. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
4. Human coronavirus NL63: a clinically important virus?
Fielding BC
Future Microbiol; 2011 Feb; 6(2):153-9. PubMed ID: 21366416
[TBL] [Abstract][Full Text] [Related]
5. Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients.
Shah P; Owens J; Franklin J; Jani Y; Kumar A; Doshi R
J Hypertens; 2020 Dec; 38(12):2537-2541. PubMed ID: 32740406
[TBL] [Abstract][Full Text] [Related]
6. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19.
Şenkal N; Meral R; Medetalibeyoğlu A; Konyaoğlu H; Kose M; Tukek T
Anatol J Cardiol; 2020 Jul; 24(1):21-29. PubMed ID: 32628137
[TBL] [Abstract][Full Text] [Related]
7. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Pranata R; Permana H; Huang I; Lim MA; Soetedjo NNM; Supriyadi R; Soeroto AY; Alkatiri AA; Firman D; Lukito AA
Diabetes Metab Syndr; 2020; 14(5):983-990. PubMed ID: 32615377
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19.
Tan ND; Qiu Y; Xing XB; Ghosh S; Chen MH; Mao R
Gastroenterology; 2020 Sep; 159(3):1170-1172.e1. PubMed ID: 32422208
[No Abstract] [Full Text] [Related]
9. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
Mehta N; Kalra A; Nowacki AS; Anjewierden S; Han Z; Bhat P; Carmona-Rubio AE; Jacob M; Procop GW; Harrington S; Milinovich A; Svensson LG; Jehi L; Young JB; Chung MK
JAMA Cardiol; 2020 Sep; 5(9):1020-1026. PubMed ID: 32936273
[TBL] [Abstract][Full Text] [Related]
10. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63.
Dijkman R; Jebbink MF; Deijs M; Milewska A; Pyrc K; Buelow E; van der Bijl A; van der Hoek L
J Gen Virol; 2012 Sep; 93(Pt 9):1924-1929. PubMed ID: 22718567
[TBL] [Abstract][Full Text] [Related]
11. A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses.
Calvo C; Alcolea S; Casas I; Pozo F; Iglesias M; Gonzalez-Esguevillas M; Luz García-García M
Pediatr Infect Dis J; 2020 Aug; 39(8):653-657. PubMed ID: 32453196
[TBL] [Abstract][Full Text] [Related]
12. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
[TBL] [Abstract][Full Text] [Related]
13. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.
Hippisley-Cox J; Young D; Coupland C; Channon KM; Tan PS; Harrison DA; Rowan K; Aveyard P; Pavord ID; Watkinson PJ
Heart; 2020 Oct; 106(19):1503-1511. PubMed ID: 32737124
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
Rico-Mesa JS; White A; Anderson AS
Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Is More Efficient than HCoV-NL63 in Infecting a Small Subpopulation of ACE2+ Human Respiratory Epithelial Cells.
Castillo G; Nelli RK; Phadke KS; Bravo-Parra M; Mora-Díaz JC; Bellaire BH; Giménez-Lirola LG
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992445
[TBL] [Abstract][Full Text] [Related]
16. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
Hofmann H; Pyrc K; van der Hoek L; Geier M; Berkhout B; Pöhlmann S
Proc Natl Acad Sci U S A; 2005 May; 102(22):7988-93. PubMed ID: 15897467
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.
Bae DJ; Tehrani DM; Rabadia SV; Frost M; Parikh RV; Calfon-Press M; Aksoy O; Umar S; Ardehali R; Rabbani A; Bokhoor P; Nsair A; Currier J; Tobis J; Fonarow GC; Dave R; Rafique AM
Am J Cardiol; 2020 Oct; 132():150-157. PubMed ID: 32819683
[TBL] [Abstract][Full Text] [Related]
18. [Coronaviruses as the cause of respiratory infections].
Corman VM; Lienau J; Witzenrath M
Internist (Berl); 2019 Nov; 60(11):1136-1145. PubMed ID: 31455974
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of human coronavirus NL63 infection and replication.
Castillo G; Mora-Díaz JC; Breuer M; Singh P; Nelli RK; Giménez-Lirola LG
Virus Res; 2023 Apr; 327():199078. PubMed ID: 36813239
[TBL] [Abstract][Full Text] [Related]
20. Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019.
Oddy C; Allington J; McCaul J; Keeling P; Senn D; Soni N; Morrison H; Mawella R; Samuel T; Dixon J
Clin Ther; 2021 Apr; 43(4):e97-e110. PubMed ID: 33712270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
